WallStSmart

eToro Group Ltd. (ETOR)vsNomura Holdings Inc ADR (NMR)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Nomura Holdings Inc ADR generates 17414% more annual revenue ($2.17T vs $12.38B). NMR leads profitability with a 16.7% profit margin vs 1.9%. NMR trades at a lower P/E of 12.1x. NMR earns a higher WallStSmart Score of 70/100 (B-).

ETOR

Buy

51

out of 100

Grade: C-

Growth: 4.0Profit: 6.5Value: 6.0Quality: 8.5
Piotroski: 3/9Altman Z: 4.09

NMR

Strong Buy

70

out of 100

Grade: B-

Growth: 7.3Profit: 6.5Value: 7.0Quality: 3.5
Piotroski: 4/9Altman Z: 0.53

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ETOR5 strengths · Avg: 8.8/10
Debt/EquityHealth
0.0210/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
4.0910/10

Safe zone — low bankruptcy risk

P/E RatioValuation
16.1x8/10

Attractively priced relative to earnings

Price/BookValuation
2.3x8/10

Reasonable price relative to book value

EPS GrowthGrowth
24.6%8/10

Earnings expanding 24.6% YoY

NMR4 strengths · Avg: 8.5/10
Price/BookValuation
1.1x10/10

Reasonable price relative to book value

PEG RatioValuation
0.828/10

Growing faster than its price suggests

P/E RatioValuation
12.1x8/10

Attractively priced relative to earnings

Revenue GrowthGrowth
27.5%8/10

Revenue surging 27.5% year-over-year

Areas to Watch

ETOR4 concerns · Avg: 2.8/10
Profit MarginProfitability
1.9%3/10

1.9% margin — thin

Operating MarginProfitability
2.8%3/10

Operating margin of 2.8%

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Revenue GrowthGrowth
-35.6%2/10

Revenue declined 35.6%

NMR4 concerns · Avg: 2.3/10
EPS GrowthGrowth
4.5%4/10

4.5% earnings growth

Free Cash FlowQuality
$-1.20T2/10

Negative free cash flow — burning cash

Altman Z-ScoreHealth
0.532/10

Distress zone — elevated risk

Debt/EquityHealth
4.671/10

Elevated debt levels

Comparative Analysis Report

WallStSmart Research

Bull Case : ETOR

The strongest argument for ETOR centers on Debt/Equity, Altman Z-Score, P/E Ratio.

Bull Case : NMR

The strongest argument for NMR centers on Price/Book, PEG Ratio, P/E Ratio. Profitability is solid with margins at 16.7% and operating margin at 18.7%. Revenue growth of 27.5% demonstrates continued momentum.

Bear Case : ETOR

The primary concerns for ETOR are Profit Margin, Operating Margin, Piotroski F-Score. Thin 1.9% margins leave little buffer for downturns.

Bear Case : NMR

The primary concerns for NMR are EPS Growth, Free Cash Flow, Altman Z-Score. Debt-to-equity of 4.67 is elevated, increasing financial risk.

Key Dynamics to Monitor

ETOR profiles as a value stock while NMR is a growth play — different risk/reward profiles.

NMR is growing revenue faster at 27.5% — sustainability is the question.

ETOR generates stronger free cash flow (102M), providing more financial flexibility.

Monitor CAPITAL MARKETS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

NMR scores higher overall (70/100 vs 51/100), backed by strong 16.7% margins and 27.5% revenue growth. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

eToro Group Ltd.

FINANCIAL SERVICES · CAPITAL MARKETS · USA

eToro Group Ltd. engages in the trading business. The company is headquartered in Bnei Brak, Israel.

Visit Website →

Nomura Holdings Inc ADR

FINANCIAL SERVICES · CAPITAL MARKETS · USA

Nomura Holdings, Inc. provides various financial services to individuals, corporations, financial institutions, governments, and government agencies worldwide. The company is headquartered in Tokyo, Japan.

Want to dig deeper into these stocks?